dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Ruiz Rodriguez, Juan Carlos |
dc.contributor.author | Molnar, Zsolt |
dc.contributor.author | Deliargyris, Efthymios N. |
dc.contributor.author | Ferrer Roca, Ricard |
dc.date.accessioned | 2022-04-07T12:39:10Z |
dc.date.available | 2022-04-07T12:39:10Z |
dc.date.issued | 2021 |
dc.identifier.citation | Ruiz-Rodríguez JC, Molnar Z, Deliargyris EN, Ferrer R. The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences. Crit Care Res Pract. 2021;2021:7769516. |
dc.identifier.issn | 2090-1313 |
dc.identifier.uri | https://hdl.handle.net/11351/7329 |
dc.description | Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Teràpia CytoSorb |
dc.language.iso | eng |
dc.publisher | Hindawi |
dc.relation.ispartofseries | Critical Care Research and Practice;2021 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | COVID-19 (Malaltia) - Mortalitat |
dc.subject | Citocines - Purificació |
dc.subject | Proteïnes de la sang |
dc.subject.mesh | Hemadsorption |
dc.subject.mesh | Cytokines |
dc.subject.mesh | /adverse effects |
dc.subject.mesh | Coronavirus Infections |
dc.title | The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1155/2021/7769516 |
dc.subject.decs | hemadsorción |
dc.subject.decs | citocinas |
dc.subject.decs | /efectos adversos |
dc.subject.decs | infecciones por Coronavirus |
dc.relation.publishversion | https://doi.org/10.1155/2021/7769516 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Ruiz-Rodríguez JC, Ferrer R] Servei de Cures Intensives, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Disfunció d'Òrgans de Xoc i Reanimació, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Molnar Z] CytoSorbents Europe GmbH, Berlin, Germany. Institute for Translational Medicine, School of Medicine, University of Pécs, Pécs, Hungary. Department of Anesthesiology and Intensive Therapy, Poznan University of Medical Sciences, Poznan, Poland. Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary. [Deliargyris EN] CytoSorbents Corporation, Monmouth Junction, NJ, USA |
dc.identifier.pmid | 34336280 |
dc.identifier.wos | 000683119800002 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |